RemeGen Co., Ltd. (688331)
SSE
114.84
+0.71 (+0.62%)
Closed
Sep 18, 2026
Day's Range
114.61118.00
52 wk Range
75.03157.80
Financial Statements - 688331 - RemeGen Co., Ltd.
Revenue
3.24B▲ 89.5%
Net Income
709.65M▲ 148.3%Net Margin 21.9%
EBITDA
454.98M▲ 141.8%
Free Cash Flow
-147.66M▲ 89.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.24B | 1.71B | 1.07B | 767.77M | 1.42B | 0 |
| Cost of Goods | 425.50M | 342.79M | 253.13M | 269.93M | 67.16M | 0 |
| Gross Profit | 2.81B | 1.36B | 822.99M | 497.83M | 1.35B | 0 |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 156.34M | -1.37B | -1.50B | -1.05B | 303.08M | -637.24M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 710.39M | -1.46B | -1.51B | -998.83M | 276.25M | -697.82M |
| Income Tax | 749K | 0 | 0 | 0 | 0 | 0 |
| Net Income | 709.65M | -1.46B | -1.51B | -998.83M | 276.25M | -697.82M |
| EPS Basic | 1.29 | -2.73 | -2.8 | -1.88 | 0.57 | -1.71 |
| EPS Diluted | 1.29 | -2.73 | -2.8 | -1.88 | 0.57 | -1.71 |
| Basic Shares Outstanding | 549.76M | 537.39M | 538.91M | 530.12M | 487.44M | 408.14M |
| Diluted Shares Outstanding | 549.76M | 537.39M | 538.91M | 530.12M | 487.44M | 408.14M |
| Ebit | 780.56M | -1.39B | -1.48B | -992.07M | 281.58M | -668.59M |
| Ebitda | 454.98M | -1.08B | -1.24B | -806.69M | 402.39M | -590.88M |
| Net Income Continuous Operations | 710.39M | -1.46B | -1.51B | -998.83M | 276.25M | -697.82M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
